GATA5 CpG island methylation in renal cell cancer: A potential biomarker for metastasis and disease progression

BJU International

Volumn 110, Issue , 2012, Pages

  Peters, Inga ^a   Eggers, Hendrik ^a   Atschekzei, Faranaz ^a   Hennenlotter, Jörg ^a   Waalkes, Sandra ^a   Tränkenschuh, Wolfgang ^a   Groãhennig, Anika ^b   Merseburger, Axel S ^a   Stenzl, Arnulf ^a   Kuczyk, Markus A ^a   Serth, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

advanced renal cell carcinoma; GATA5; hypermethylation; metastasis; survival

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR GATA 5; TUMOR MARKER;

ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PYROSEQUENCING; RESTRICTION MAPPING; SURVIVAL RATE;

AGED; CARCINOMA, RENAL CELL; CPG ISLANDS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GATA5 TRANSCRIPTION FACTOR; HUMANS; KIDNEY NEOPLASMS; MALE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84860595187     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10862.x     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, et al,. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
2. Ferlay J, Shin HR, Bray F, et al,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917
3. Levi F, Ferlay J, Galeone C, et al,. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 2008; 101: 949-58
4. Ljungberg B,. Prognostic factors in renal cell carcinoma. Urologe A 2004; 43 (Suppl. 3): 119-20
5. Sanger Institute. Tissue Overview for Kidney. Available at:. Accessed May 2011
6. Dalgliesh GL, Furge K, Greenman C, et al,. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010; 463: 360-3
7. Varela I, Tarpey P, Raine K, et al,. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011; 469: 539-42
8. Morris MR, Ricketts C, Gentle D, et al,. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene 2010; 29: 2104-17
9. Laird PW,. Cancer epigenetics. Hum Mol Genet 2005; 14: 65-76
10. Widschwendter M, Jones PA,. DNA methylation and breast carcinogenesis. Oncogene 2002; 21: 5462-82
11. Esteller M,. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-59
12. Morrissey C, Martinez A, Zatyka M, et al,. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 2001; 61: 7277-81
13. Dahl E, Wiesmann F, Woenckhaus M, et al,. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene 2007; 26: 5680-91
14. Onay H, Pehlivan S, Koyuncuoglu M, Kirkali Z, Ozkinay F,. Multigene methylation analysis of conventional renal cell carcinoma. Urol Int 2009; 83: 107-12
15. Peters I, Rehmet K, Wilke N, et al,. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis. Mol Cancer 2007; 6: 49
16. Ibanez De Caceres I, Dulaimi E, Hoffman AM, et al,. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 2006; 66: 5021-8
17. Pflug BR, Zheng H, Udan MS, et al,. Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor. Cancer Lett 2007; 246: 139-48
18. Morris MR, Gentle D, Abdulrahman M, et al,. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br J Cancer 2008; 98: 496-501
19. Van Vlodrop IJ, Baldewijns MM, Smits KM, et al,. Prognostic significance of Gremlin1 (GREM1) promoter Cpg Island hypermethylation in clear cell renal cell carcinoma. Am J Pathol 2010; 176: 575-84
20. Morris MR, Ricketts CJ, Gentle D, et al,. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 2011; 30: 1390-401
21. Lopez-Lago MA, Thodima VJ, Guttapalli A, et al,. Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression. Cancer Res 2010; 70: 9682-92
22. National Center for Biotechnology Information. DATA Set Browser. Available at:. Accessed August 2010
23. Human Genome Browser. UCSC Genome Browser on Human Feb. 2009. Available at:. Accessed August 2010
24. Merika M, Orkin SH,. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol 1993; 13: 3999-4010
25. Morrisey EE, Ip HS, Tang Z, Lu MM, Parmacek MS,. GATA-5: a transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic development. Dev Biol 1997; 183: 21-36
26. Gao X, Sedgwick T, Shi YB, Evans T,. Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol Cell Biol 1998; 18: 2901-11
27. Akiyama Y, Watkins N, Suzuki H, et al,. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 2003; 23: 8429-39
28. Wen X-Z, Akiyama Y, Pan K-F, et al,. Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J Gastroenterol 2010; 16: 1201-8
29. Sobin LH, Compton CC,. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010; 116: 5336-9
30. Peters I, Vaske B, Albrecht K, et al,. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue. Cancer Epidemiol Biomarkers Prev 2007; 16: 2526-32
31. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R,. Sensitive and quantitative universal pyrosequencing methylation analysis of Cpg sites. Biotechniques 2003; 35: 146-50
32. The R Project For Statistical Computing. Available at:. Accessed March 2010
33. Kampstra P,. Beanplot: a boxplot alternative for visual comparison of distributions. JSS, Code Snippets 2008; 28: 1-9
34. Hothorn T,. On the exact distribution of maximally selected rank statistics. Comput Stat Data Anal 2003; 43: 121-37
35. Guo M, Akiyama Y, House MG, et al,. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res 2004; 10: 7917-24
36. Guo M, House MG, Akiyama Y, et al,. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer 2006; 119: 2078-83
37. Wakana K, Akiyama Y, Aso T, Yuasa Y,. Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis. Cancer Lett 2006; 241: 281-8
38. Fu B, Guo M, Wang S, et al,. Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types. Cancer Biol Ther 2007; 6: 1546-52
39. Chun CZ, Tsai HJ, Chen TT,. Trout Ea4- or human Eb-Peptide of pro-IGF-I disrupts heart, red blood cell, and vasculature development in zebrafish embryos. Mol Reprod Dev 2006; 73: 1112-21
40. Clifford SC, Cockman ME, Smallwood AC, et al,. Contrasting effects on HIF-1alpha regulation by disease-causing Pvhl mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 2001; 10: 1029-38